Goldman Sachs
EDSA icon

Goldman Sachs’s Edesa Biotech EDSA Stock Holding History

Goldman Sachs’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-297
Closed -$17K – 5331
2018
Q3 		$17K Buy
+297
New +$18.9K ﹤0.01% 5425

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Goldman Sachs's EDSA Position: Q4 2018 in Review

Goldman Sachs sold out of Edesa Biotech (EDSA) in Q4 2018, closing a stake of 297 shares — an estimated $17K sold.

Goldman Sachs first reported a position in EDSA in Q3 2018 and held it in 1 quarter. The position peaked at $17K in Q3 2018. 10 funds tracked by Wall St. Rank hold EDSA as of Q4 2018.

  • Goldman Sachs reported no remaining Edesa Biotech position as of Q4 2018 after selling out during the quarter.
  • Goldman Sachs sold 297 Edesa Biotech shares in Q4 2018, an estimated $17K.
  • Goldman Sachs first reported a position in Edesa Biotech in Q3 2018 and held it in 1 quarter.
  • Goldman Sachs's Edesa Biotech position peaked at $17K in Q3 2018.
  • 10 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.